OnKure Therapeutics, Inc. (OKUR)
NASDAQ: OKUR · Real-Time Price · USD
2.630
+0.070 (2.73%)
At close: Oct 5, 2026, 4:00 PM EDT
2.670
+0.040 (1.52%)
After-hours: Oct 5, 2026, 7:30 PM EDT
OnKure Therapeutics Employees
OnKure Therapeutics had 45 employees as of December 31, 2025. The number of employees decreased by 1 or -2.17% compared to the previous year.
Employees
45
Change (1Y)
-1
Growth (1Y)
-2.17%
Revenue / Employee
n/a
Profits / Employee
-$1,304,556
Market Cap
106.51M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 45 | -1 | -2.17% |
| Dec 31, 2024 | 46 | -3 | -6.12% |
| Jun 30, 2024 | 50 | - | - |
| Mar 31, 2024 | 49 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Cellectis | 229 |
| LENZ Therapeutics | 152 |
| Immunic | 100 |
| PolyPid | 75 |
| Vivani Medical | 42 |
| Aardvark Therapeutics | 28 |
| Black Diamond Therapeutics | 21 |
| Tevogen | 18 |
OKUR News
- 5 weeks ago - OnKure Therapeutics to Participate in the Morgan Stanley Global Healthcare Conference - GlobeNewsWire
- 7 weeks ago - OnKure Therapeutics price target lowered to $14 from $30 at Oppenheimer - TheFly
- 2 months ago - OnKure Therapeutics reports Q2 EPS (31c), consensus (54c) - TheFly
- 2 months ago - OnKure Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Highlights - GlobeNewsWire
- 2 months ago - OnKure Therapeutics Slides: Corporate presentation - Filings
- 2 months ago - OnKure Therapeutics Quarterly report: Q2 2026 - Filings
- 2 months ago - OnKure Therapeutics Earnings release: Q2 2026 - Filings
- 2 months ago - OnKure Therapeutics price target lowered to $21 from $27 at H.C. Wainwright - TheFly